Literature DB >> 12869584

The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor.

Casey J Fox1, Peter S Hammerman, Ryan M Cinalli, Stephen R Master, Lewis A Chodosh, Craig B Thompson.   

Abstract

Growth factor withdrawal results in the termination of factor-dependent transcription. One transcript that declines rapidly following growth factor deprivation of hematopoietic cells is the serine/threonine kinase pim-2. When constitutively expressed, Pim-2 conferred long-term resistance to a variety of apoptotic stimuli including growth factor withdrawal and endogenous levels of Pim-2 contributed to growth factor-mediated apoptotic resistance. Pim-2 expression maintained cell size and mitochondrial potential independently of the PI3K/Akt/TOR pathway. Pim-2-dependent maintenance of cell size and survival correlated with its ability to maintain rapamycin-resistant phosphorylation of the translational repressor 4E-BP1 and phosphorylation of the BH3 protein BAD. These results establish Pim-2 as a direct link between growth factor-induced transcription and a novel, kinase-dependent pathway that promotes cell-autonomous survival.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869584      PMCID: PMC196230          DOI: 10.1101/gad.1105003

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  50 in total

1.  In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability.

Authors:  J C Rathmell; M G Vander Heiden; M H Harris; K A Frauwirth; C B Thompson
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

2.  Neurosteroid analogues. 8. Structure-activity studies of N-acylated 17a-aza-D-homosteroid analogues of the anesthetic steroids (3alpha, 5alpha)- and (3alpha,5beta)-3-hydroxypregnan-20-one.

Authors:  D F Covey; M Han; A S Kumar; M A de La Cruz; E S Meadows; Y Hu; A Tonnies; D Nathan; M Coleman; A Benz; A S Evers; C F Zorumski; S Mennerick
Journal:  J Med Chem       Date:  2000-08-24       Impact factor: 7.446

3.  Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology.

Authors:  D R Plas; S Talapatra; A L Edinger; J C Rathmell; C B Thompson
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

4.  Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition.

Authors:  J Li; G W Peet; D Balzarano; X Li; P Massa; R W Barton; K B Marcu
Journal:  J Biol Chem       Date:  2001-02-21       Impact factor: 5.157

5.  Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples.

Authors:  S Yoshida; Y Kaneita; Y Aoki; M Seto; S Mori; M Moriyama
Journal:  Oncogene       Date:  1999-12-23       Impact factor: 9.867

6.  Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc.

Authors:  J D Allen; E Verhoeven; J Domen; M van der Valk; A Berns
Journal:  Oncogene       Date:  1997-09-04       Impact factor: 9.867

7.  Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death.

Authors:  T J Pircher; S Zhao; J N Geiger; B Joneja; D M Wojchowski
Journal:  Oncogene       Date:  2000-07-27       Impact factor: 9.867

8.  Pim-1 negatively regulates the activity of PTP-U2S phosphatase and influences terminal differentiation and apoptosis of monoblastoid leukemia cells.

Authors:  Z Wang; N Bhattacharya; M K Meyer; H Seimiya; T Tsuruo; J A Tonani; N S Magnuson
Journal:  Arch Biochem Biophys       Date:  2001-06-01       Impact factor: 4.013

9.  Delineation of prognostic biomarkers in prostate cancer.

Authors:  S M Dhanasekaran; T R Barrette; D Ghosh; R Shah; S Varambally; K Kurachi; K J Pienta; M A Rubin; A M Chinnaiyan
Journal:  Nature       Date:  2001-08-23       Impact factor: 49.962

Review 10.  Fos family members: regulation, structure and role in oncogenic transformation.

Authors:  E Tulchinsky
Journal:  Histol Histopathol       Date:  2000-07       Impact factor: 2.303

View more
  118 in total

1.  Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammation.

Authors:  Yoo Seob Shin; Katsuyuki Takeda; Yoshiki Shiraishi; Yi Jia; Meiqin Wang; Leila Jackson; A Dale Wright; Laura Carter; John Robinson; Erik Hicken; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2011-11-10       Impact factor: 6.914

2.  Suppression of dendritic cell-mediated responses by genes in calcium and cysteine protease pathways during Mycobacterium tuberculosis infection.

Authors:  Jhalak Singhal; Neha Agrawal; Mohit Vashishta; N Gayatri Priya; Brijendra K Tiwari; Yogendra Singh; Rajagopal Raman; Krishnamurthy Natarajan
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

3.  Targeted cancer therapy: what if the driver is just a messenger?

Authors:  Jonathan H Schatz; Hans-Guido Wendel
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

4.  Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD.

Authors:  Shoba Amarnath; Francis A Flomerfelt; Carliann M Costanzo; Jason E Foley; Jacopo Mariotti; Daniel M Konecki; Anu Gangopadhyay; Michael Eckhaus; Susan Wong; Bruce L Levine; Carl H June; Daniel H Fowler
Journal:  Autophagy       Date:  2010-05-16       Impact factor: 16.016

Review 5.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

6.  PI3K-like kinases restrain Pim gene expression in endothelial cells.

Authors:  Xinwen Min; Jie Tang; Yinfang Wang; Minghua Yu; Libing Zhao; Handong Yang; Peng Zhang; Yexin Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

Review 7.  PIM1: a promising target in patients with triple-negative breast cancer.

Authors:  Wen Zhao; RuiYue Qiu; Pan Li; Jin Yang
Journal:  Med Oncol       Date:  2017-07-18       Impact factor: 3.064

Review 8.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  Expression of human pim family genes is selectively up-regulated by cytokines promoting T helper type 1, but not T helper type 2, cell differentiation.

Authors:  Teija L T Aho; Riikka J Lund; Emmi K Ylikoski; Sampsa Matikainen; Riitta Lahesmaa; Päivi J Koskinen
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

10.  Adipocytes impair leukemia treatment in mice.

Authors:  James W Behan; Jason P Yun; Marina P Proektor; Ehsan A Ehsanipour; Anna Arutyunyan; Ara S Moses; Vassilios I Avramis; Stan G Louie; Anna Butturini; Nora Heisterkamp; Steven D Mittelman
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.